Beate Sander, RN MBA MEcDev PhD, is Director of Population Health Economics Research (PHER) at the Toronto General Hospital Research Institute and Director of Health Modeling & Health Economics at the Toronto Health Economics and Technology Assessment collaborative (THETA). She provides scientific advice to decision makers and serves on scientific working groups and advisory bodies, including Canada’s National Advisory Committee on Immunization (NACI), where she also chairs the Economics Task Group. She is a Scientific Co-Chair of the Canadian Lyme Disease Research Network. Dr. Sander is Vice President of the Society of Medical Decision Making and an editorial board member of the Medical Decision Making journal.

Dr. Sander's areas of expertise include health economics, decision analysis and simulation, infectious disease epidemiology, and population health decision-making. Her research focuses on economic evaluation, ranging from methods development to applied research on infectious diseases. She leads large multidisciplinary international teams evaluating Zika and West Nile virus mitigation strategies using data-driven simulation models, and estimating the burden of infectious diseases (C.difficile, S.pneumoniae, hepatitis, West Nile virus, Lyme disease) using linked population-based data. She has spearheaded the linkage of laboratory and reportable disease data with administrative data, enabling novel approaches to study the burden of infectious diseases.

For a list of Dr. Sander's publications, please visit PubMed or Scopus.

Senior Scientist, Toronto General Hospital Research Institute (TGHRI)

Associate Professor (status-only), Institute of Health Policy, Management and Evaluation, University of Toronto
Adjunct Scientist, ICES
Scientist, Public Health Ontario
Associate, Canadian Centre for Health Economics
Canada Research Chair in Economics of Infectious Diseases (Tier 2)